Income Statement Kulicke and Soffa Industries, Inc.
Equities
KLIC
US5012421013
Semiconductor Equipment & Testing
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.42 USD | +2.13% | -1.53% | -11.51% |
Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 623M | 1.52B | 1.5B | 742M | 706M | |||||
Total Revenues | 623M | 1.52B | 1.5B | 742M | 706M | |||||
Cost of Goods Sold, Total | 325M | 821M | 755M | 384M | 377M | |||||
Gross Profit | 298M | 697M | 748M | 359M | 329M | |||||
Selling General & Admin Expenses, Total | 121M | 145M | 141M | 153M | 160M | |||||
R&D Expenses | 123M | 137M | 137M | 145M | 151M | |||||
Other Operating Expenses, Total | 244M | 283M | 278M | 298M | 312M | |||||
Operating Income | 54.01M | 414M | 470M | 60.97M | 17.34M | |||||
Interest Expense, Total | -1.72M | -218K | -208K | -142K | -89K | |||||
Interest And Investment Income | 7.54M | 2.32M | 7.12M | 32.91M | 34.23M | |||||
Net Interest Expenses | 5.82M | 2.1M | 6.92M | 32.76M | 34.14M | |||||
Income (Loss) On Equity Invest. | -36K | -94K | - | - | - | |||||
EBT, Excl. Unusual Items | 59.8M | 416M | 477M | 93.74M | 51.48M | |||||
Restructuring Charges | - | - | - | - | -110M | |||||
Merger & Related Restructuring Charges | - | -1.7M | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Asset Writedown | - | - | - | -21.54M | - | |||||
Other Unusual Items | 4.5M | - | - | - | - | |||||
EBT, Incl. Unusual Items | 64.3M | 414M | 477M | 72.2M | -58.36M | |||||
Income Tax Expense | 12M | 47.3M | 43.44M | 15.05M | 10.65M | |||||
Earnings From Continuing Operations | 52.3M | 367M | 434M | 57.15M | -69.01M | |||||
Net Income to Company | 52.3M | 367M | 434M | 57.15M | -69.01M | |||||
Net Income - (IS) | 52.3M | 367M | 434M | 57.15M | -69.01M | |||||
Net Income to Common Incl Extra Items | 52.3M | 367M | 434M | 57.15M | -69.01M | |||||
Net Income to Common Excl. Extra Items | 52.3M | 367M | 434M | 57.15M | -69.01M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.83 | 5.92 | 7.21 | 1.01 | -1.24 | |||||
Basic EPS - Continuing Operations | 0.83 | 5.92 | 7.21 | 1.01 | -1.24 | |||||
Basic Weighted Average Shares Outstanding | 62.83M | 62.01M | 60.16M | 56.68M | 55.61M | |||||
Net EPS - Diluted | 0.83 | 5.78 | 7.09 | 0.99 | -1.24 | |||||
Diluted EPS - Continuing Operations | 0.83 | 5.78 | 7.09 | 0.99 | -1.24 | |||||
Diluted Weighted Average Shares Outstanding | 63.36M | 63.52M | 61.18M | 57.55M | 55.61M | |||||
Normalized Basic EPS | 0.59 | 4.19 | 4.96 | 1.03 | 0.58 | |||||
Normalized Diluted EPS | 0.59 | 4.1 | 4.87 | 1.02 | 0.58 | |||||
Dividend Per Share | 0.48 | 0.56 | 0.68 | 0.76 | 0.8 | |||||
Payout Ratio | 57.81 | 9.11 | 9.08 | 73.56 | -64 | |||||
Supplemental Items | ||||||||||
EBITDA | 73.75M | 434M | 491M | 89.83M | 42.08M | |||||
EBITA | 61.38M | 420M | 475M | 67.07M | 22.53M | |||||
EBIT | 54.01M | 414M | 470M | 60.97M | 17.34M | |||||
EBITDAR | 80.69M | 442M | 500M | 101M | 52.09M | |||||
Effective Tax Rate - (Ratio) | 18.66 | 11.41 | 9.11 | 20.85 | -18.25 | |||||
Current Domestic Taxes | - | - | - | 10.28M | -1.65M | |||||
Current Foreign Taxes | - | - | - | 8.83M | 2.62M | |||||
Total Current Taxes | 11.73M | 57.6M | 52.67M | 19.11M | 967K | |||||
Deferred Domestic Taxes | - | - | - | 1.3M | 101K | |||||
Deferred Foreign Taxes | - | - | - | -5.36M | 9.58M | |||||
Total Deferred Taxes | 272K | -10.3M | -9.23M | -4.06M | 9.68M | |||||
Normalized Net Income | 37.37M | 260M | 298M | 58.58M | 32.18M | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 123M | 137M | 137M | 145M | 151M | |||||
Net Rental Expense, Total | 6.94M | 7.63M | 8.62M | 10.75M | 10.02M | |||||
Imputed Operating Lease Interest Expense | 1.92M | 396K | 339K | 271K | 160K | |||||
Imputed Operating Lease Depreciation | 5.02M | 7.23M | 8.29M | 10.48M | 9.86M | |||||
Stock-Based Comp., COGS (Total) | 744K | 828K | 960K | 1.19M | 1.28M | |||||
Stock-Based Comp., R&D Exp. (Total) | 3.2M | 3.68M | 4.12M | 5.31M | 7.09M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 11.07M | 11M | 13.91M | 16.24M | 18.52M | |||||
Total Stock-Based Compensation | 15.02M | 15.5M | 18.99M | 22.74M | 26.89M |